Crystallographic Study, Biological Evaluation and Docking/MD/POM Analyses of Isoxazole-Linked Sulfonate Ester Conjugates
Authors:
- Aziz ArzineAAAziz Arzine
- Khaoula FaizKFKhaoula Faiz
- Amal BouribabABAmal Bouribab
- Najoua SouloNSNajoua Soulo
- Pascal RetailleauPRPascal Retailleau
- Mohammed ChalkhaMohammed Chalkha
- Asmae NakkabiANAsmae Nakkabi
- Samir ChtitaSCSamir Chtita
- Bouchra LouastéBLBouchra Louasté
- Taibi Ben HaddaTaibi Ben Hadda
- Karim ChkirateKCKarim Chkirate
- Joel T. MagueJMJoel T. Mague
Open Access
Abstract
In the present study, a series of isoxazole derivatives were severally evaluated for their antifungal activity against the yeast Candida albicans and molds such as Aspergillus niger, Aspergillus flavus, and Fusarium oxysporum. The results demonstrate that the isoxazole derivatives exhibit considerable antifungal potential, particularly isoxazole-sulfonate ester 4b (Ar= 4-(Cl)C6H4, Ar′= 4-(CH3)C6H4), which was found to be active with significant inhibition zones; the diameters of the C. albicans and F. oxysporum samples were measured at 17.00 ± 0.00 mm and 14.00 ± 0.00 mm, respectively. Furthermore, compounds 4a (Ar= 4-(CH3)C6H4, Ar′= 4-(CH3)C6H4), 4c (Ar: 4-(Cl)C6H4, Ar′: 4-(NO2)C6H4) and 4d (Ar: 4-(Cl)C6H4, Ar′: 3-(Cl)-2-(OCH3)C6H3) demonstrated MIC and MFC values of 20 µg/mL against C. albicans. In addition, the anti-hemolytic activity of these derivatives was evaluated. Compounds 4a, 4e (Ar: 4-(Cl)C6H4, Ar′: 3,4-(OCH3)2C6H3) and aroylisoxazole 3a (Ar: 4-(CH3)C6H4) demonstrated a high degree of anti-hemolytic activity (>99%) at all concentrations evaluated (10, 15, and 20 mg/mL). Molecular docking and molecular dynamics studies over 200 ns revealed protein–ligand complexes to have high affinity and stability, which agrees with the experimental results. The compounds 4d, 4e, and 3a have shown significant interaction with the target proteins of C. albicans, A. flavus, and F. oxysporum, respectively. The results have revealed that the major interaction sites are hydrogen bonding, hydrophobic interactions, and the presence of a water molecule, especially with key residues like TYR_84, ASP_120, SER_90, and THR_89. The crystal structure of compound 4a was also obtained.Keywords
Funding Information
- Ongoing Research Funding Program (ORF-2026-418)
This publication has 71 references indexed in Scilit:
- Advances in Five‐Membered Heterocyclic Scaffolds as Anti‐Tuberculosis Agents: A Decade of DiscoveryArchiv der Pharmazie, 2026
- Design, Synthesis, In Vitro, and In Silico Evaluation of Isoxazole–Isoxazoline Conjugates as Potential Antimicrobial AgentsChemistry & Biodiversity, 2025
- Antimicrobial activity of isoxazole derivatives: A brief overviewVietnam Journal of Chemistry, 2024
- Exploring the Diverse Biological Frontiers of Isoxazole: A Comprehensive Review of its Pharmacological SignificanceChemistrySelect, 2024
- Synthesis, antifungal evaluation, two‐dimensional quantitative structure–activity relationship and molecular docking studies of isoxazole derivatives as potential fungicidesPest Management Science, 2024
- Na 2 S 2 O 3 Catalyzed Three‐Component Synthesis and Anti‐Bacterial Activity of 3‐Methyl‐4‐(hetero)arylmethylene isoxazole‐5(4 H )‐onesChemistry & Biodiversity, 2024
- In vitro and in vivo assessment of the anti-inflammatory activity of olive leaf extract in ratsInflammopharmacology, 2023
- The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS‐CoV‐2 targetsPhytotherapy Research, 2020
- Isoxazole‐Derived Aroylhydrazones and Their Dinuclear Copper(II) Complexes Show Antiproliferative Activity on Breast Cancer Cells with a Potentially Alternative Mechanism Of ActionChemBioChem, 2020
- The synthetic and therapeutic expedition of isoxazole and its analogsMedicinal Chemistry Research, 2018